FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to novel medication for treatment of purulent-inflammatory processes of skin and mucous membranes of different etiology. Medication is made in form of gel and contains the following ingredients with the following ratio of components in g per 100 g: biocomplex of metronidazole with zinc 0.5-2.0, biocomplex of furacilinum with copper 0.1-0.2, trimecaine 3.0-5.0, vitamins (vitamin A, vitamin E, vitamin PP, vitamin C or their mixture) 0.1-1.0, dimexide 10.0, hydrogel of methylsiliconic acid 1.0-5.0, hydrophilic base 3.0-7.0, water 82.3-69.8.
EFFECT: extension of assortment of wound-healing medications.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LOCAL PHARMACEUTICAL ANTIBACTERIAL COMPOSITION OF ACTIVE BIOMETALLIC COMPLEXES | 2011 |
|
RU2489147C2 |
| WOUND-HEALING MEDICATION FOR LOCAL APPLICATION | 2011 |
|
RU2481835C2 |
| METHOD OF VARIOUS SUPPULATIVE-INFLAMMATORY SKIN AND MUCOUS PROCESS TREATMENT | 2005 |
|
RU2326681C2 |
| AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
| AGENT FOR TREATMENT OF WOUNDS, BURNS AND INFLAMMATORY SKIN DISEASES | 2020 |
|
RU2744545C1 |
| AGENT FOR TREATING SKIN DAMAGES AND METHOD FOR PRODUCTION THEREOF (EMBODIMENTS) | 2019 |
|
RU2716158C1 |
| MEDICINE FOR BACTERIAL VAGINOSIS (VARIANTS) | 2007 |
|
RU2325148C1 |
| EXTERNAL AND LOCAL PHARMACEUTICAL STEPHAGLABRIN PREPARATION | 2007 |
|
RU2364399C1 |
| STEPHAGLABRIN-BASED PHARMACEUTICAL COMPOSITION OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF TRAUMATIC AND POST-OPERATION INJURY OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2371172C2 |
| ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
